Another Co. Surrenders In Seroquel XR Patent Fight
Intellipharmaceutics Corp. has settled patent infringement claims brought by AstraZeneca Pharmaceuticals LP over plans to market a generic version of anti-psychotic drug Seroquel XR, agreeing Monday to delay the launch of its...To view the full article, register now.
Already a subscriber? Click here to view full article